Provided by Tiger Trade Technology Pte. Ltd.

Tandem Diabetes Care

16.50
0.0000
Post-market: 16.500.00000.00%16:04 EDT
Volume:2.19M
Turnover:36.55M
Market Cap:1.15B
PE:-17.79
High:17.35
Open:16.66
Low:16.27
Close:16.50
52wk High:29.65
52wk Low:12.26
Shares:69.58M
Float Shares:63.59M
Volume Ratio:0.90
T/O Rate:3.45%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.9274
EPS(LYR):-3.0424
ROE:-48.03%
ROA:-2.65%
PB:8.80
PE(LYR):-5.42

Loading ...

Tandem Diabetes Care Schedules Third-Quarter Results Conference Call

Reuters
·
Yesterday

Tandem Diabetes Care, Inc. : Citigroup Cuts Target Price to $20 from $24

THOMSON REUTERS
·
Sep 30

Tandem Diabetes Launches Mobi Insulin Delivery System in 12 International Markets

Reuters
·
Sep 28

Tandem Diabetes Care is Maintained at Buy by Truist Securities

Dow Jones
·
Sep 25

Truist Lowers Price Target on Tandem Diabetes Care to $28 From $31, Keeps Buy Rating

MT Newswires Live
·
Sep 24

Tandem Diabetes initiated with an Outperform at William Blair

TIPRANKS
·
Aug 21

How Tandem’s Q2 Loss and Pharmacy Pivot Will Impact Tandem Diabetes Care (TNDM) Investors

Simply Wall St.
·
Aug 20

Tandem Diabetes price target raised to $24 from $21 at Citi

TIPRANKS
·
Aug 17

Citi Sticks to Its Hold Rating for Tandem Diabetes Care (TNDM)

TIPRANKS
·
Aug 14

Tandem Diabetes Care: Buy Rating Reaffirmed on Transformation Momentum and Innovation Catalysts; $40 Price Target Maintained

TIPRANKS
·
Aug 12

Tandem Diabetes Care Price Target Raised to $21.00/Share from $17.00 by Citigroup

Dow Jones
·
Aug 08

Tandem Diabetes Care's Underlying Q2 Trends Better Than Headline Suggests, RBC Says

MT Newswires Live
·
Aug 08

Stifel Nicolaus Reaffirms Their Hold Rating on Tandem Diabetes Care (TNDM)

TIPRANKS
·
Aug 08

RBC Adjusts PT on Tandem Diabetes Care to $26 From $30, Maintains Outperform Rating

MT Newswires Live
·
Aug 07

Tandem Diabetes price target raised to $40 from $35 at Canaccord

TIPRANKS
·
Aug 07

Tandem Diabetes Care, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 07

Tandem Diabetes Care Q2 EPS $(0.31) Beats $(0.32) Estimate, Sales $254.560M Miss $254.978M Estimate

Benzinga Earnings
·
Aug 07

Tandem Diabetes Care Q2 Net Income USD -21.2 Million

Reuters
·
Aug 07

Tandem Diabetes Care Q2 EPS USD -0.31

THOMSON REUTERS
·
Aug 07

DexCom Glucose Monitors' National Coverage Could Support H2 Upside, RBC Capital Markets Says

MT Newswires Live
·
Jul 31